drugset / Trial / NCT01685762

Metformin for the Treatment of Endometrial Hyperplasia

NCT01685762

Phase 0 Completed 18 enrolled UNC Lineberger Comprehensive Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see if metformin will be effective in making endometrial hyperplasia without atypia better by returning the tissue to a normal state.

Timeline

Start
2013-01-10
Primary completion
2015-12-01
Completion
2015-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 850 mg Oral